The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung

Journal of Clinical Investigation

Volumn 99, Issue 9, 1997, Pages 2110-2117

  Limper, Andrew H ^a,b,c   Hoyte, Jacques S ^a   Standing, Joseph E ^a  

^a Division of Pulmonary   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

bisphosphonates; liposome; macrophage; phagocytosis; Pneumocystis carinii

Indexed keywords

CLODRONIC ACID; GLYCOPROTEIN; LIPOSOME; PROTOZOAL PROTEIN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HOST PARASITE INTERACTION; HOST RESISTANCE; INOCULATION; LUNG ALVEOLUS MACROPHAGE; LUNG CLEARANCE; LUNG LAVAGE; LYMPHOCYTE DEPLETION; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RAT;

EID: 0030959990     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119384     Document Type: Article

References (61)

1. Limper, A.H., K.P. Offord, T.F. Smith, and W.J. Martin. 1989. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204-1209.
2. Cohn, D.L., D.E. Stover, R.F. O'Brien, J.H. Shelhamer, T.A. Raffin, and P.C. Hopewell. 1988. Pulmonary complications of AIDS: advances in diagnosis and treatment. Am. Rev. Respir. Dis. 138:1051-1052.
3. Murray, J.G., and J. Mills. 1990. Pulmonary infectious complications of human immunodeficiency virus infection. Am. Rev. Respir. Dis. 141:1582-1598.
4. Sepkowitz, K.A., A.E. Brown, E.E. Telzak, S. Gottlieb, and D. Armstrong. 1992. Pneumocystis carinii pneumonia among patients without AIDS in a cancer hospital. JAMA (J. Am. Med. Assoc.). 267:832-837.
5. Peters, S.G., and U.B.S. Prakash. 1987. Pneumocystis carinii pneumonia. Am. J. Med. 82:73-78.
6. Centers for Disease Control. 1989. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons with human immunodeficiency virus infection. MMWR (Morb. Mortal. Wkly. Rep.). 38:1-8.
7. Limper, A.H. 1991. Parasite adherence and host responses in the development of Pneumocystis carinii pneumonia. Semin. Respir. Infect. 6:19-26.
8. Yale, S.H., and A.H. Limper. 1996. Role of corticosteroids in development of Pneumocystis carinii pneumonia in patients without AIDS. Mayo Clin. Proc. 71:5-13.
9. Shellito, J., V.V. Suzara, W. Blumenfeld, J.M. Beck, H.J. Steger, and T.H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Invest. 85:1686-1693.
10. Masur, H., H.C. Lane, J.A. Kovacs, C.J. Allegra, and J.C Edman. 1989. NIH conference. Pneumocystis pneumonia: from bench to clinic. Ann. Intern. Med. 111:813-826.
11. Beck, J.M., M.L. Warnock, J.L. Curtis, M.J. Sniezek, S.M. Arraj-Peffer, H.B. Kaltreider, and J.E. Shellito. 1991. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am. J. Respir. Cell Mol. Biol. 5:186-197.
12. Von Behren, L.A., and E.L. Pesanti. 1978. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Rev. Respir. Dis. 118:1051-1059.
13. Masur, H., and T.C. Jones. 1978. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J. Exp. Med. 147:157-170.
14. Koziel, H., D. O'Riordan, A. Warner, and R.M. Rose. 1994. Alveolar macrophage interaction with Pneumocystis carinii. Immunol. Ser. 60:417-136.
15. Laursen, A.L., N. Obel, J. Rungby, and P.L. Anderson. 1993. Phagocytosis and stimulation of the respiratory burst in neutrophils by Pneumocystis carinii. J. Infect. Dis. 168:1466-1471.
16. Mason, G.R., C.H. Hashimoto, P.S. Dickman, L.F. Foutty, and C.J. Cobb. 1989. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am. Rev. Respir. Dis. 139:1336-1342.
17. Ezekowitz, R.A.B., D.J. Williams, H. Kozial, M.Y.K. Armstrong, A. Warner, F.F. Richards, and R.M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature (Lond.). 351:155-158.
18. Castro, M., T.I. Morgenthaler, O.A. Hoffman, M.S. Rohrbach, and A.H. Limper. 1993. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 9:73-81.
19. Hidalgo, H.A., R.J. Helmke, V.F. German, and J.A. Mangos. 1992. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect. Immun. 60:1-7.
20. O'Riordan, D.M., J.E. Standing, and A.H. Limper. 1995. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect. Immun. 63: 779-784.
21. Hoffman, O.A., J.E. Standing, and A.H. Limper. 1993. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a β-glucan-mediated mechanism. J. Immunol. 150:3932-3940.
22. Neese, L.W., J.E. Standing, E.J. Olson, M. Castro, and A.H. Limper. 1994. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-alpha in response to Pneumocystis carinii. J. Immunol. 152:4549-4556.
23. Pottratz, S.T., and W.J. Martin. 1990. Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J. Clin. Invest. 86:1678-1683.
24. Koziel, H., B.A. Kruskal, R.A. Ezekowitz, and R.M. Rose. 1993. HIV impairs alveolar macrophage mannose receptor function against Pneumocystis carinii. Chest. 103(Suppl):111S-112S.
25. Kovacs, J.A., F. Powell, J.C. Edman, B. Lundgren, A. Martinez, B. Drew, and C.W. Angus. 1993. Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. J. Biol. Chem. 268:6034-6040.
26. Gigliotti, F. 1992. Host species-specific variation of a mannosylated surface glycoprotein of Pneumocystis carinii. J. Infect. Dis. 165:329-336.
27. Linke, M.J., M.T. Cushion, and P.D. Walzer. 1989. Properties of the major antigens of rat and human Pneumocystis carinii. Infect. Immun. 57:1547-155.
28. Radding, J.A., M.Y.K. Armstrong, E. Ullu, and F.F. Richards. 1989. Identification and isolation of a major cell surface glycoprotein of Pneumocystis carinii. Infect. Immun. 57:2149-2157.
29. Cushion, M.T., J.A. DeStefano, P.D. Walzer. 1988. Pneumocystis carinii: surface reactive carbohydrates detected by lectin probes. Exp. Parasitol 67: 137-147.
30. Haidaris, P.J., T.W. Wright, F. Gigliotti, and C.G. Haidaris. 1992. Expression and characterization of a cDNA clone encoding an immunodominant surface glycoprotein of Pneumocystis carinii. J. Infect. Dis. 166:1113-1123.
31. Stringer, S.L., T. Garbe, S.M. Suskin, and J.R. Stringer. 1993. Genes encoding antigenic surface glycoproteins in Pneumocystis carinii in humans. J. Eukaryot. Microbiol. 40:821-826.
32. Lundgren, B., G.Y. Lipchik, and J.A. Kovacs. 1991. Purification and characterization of a major human Pneumocystis carinii surface antigen. J. Clin. Invest. 87:163-170.
33. Kolls, J.K., J.M. Beck, S. Nelson, W.A. Summer, and J. Shellito. 1993. Alveolar macrophage release of tumor necrosis factor-alpha during murine Pneumocystis carinii pneumonia. Am. J. Resp. Cell Mol. biol. 8:370-376.
34. Theus, S.A., M.J. Linke, R.P. Andrews, and P.D. Walzer. 1993. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii. Infect. Immun. 61:4703-4709.
35. Gigliotti, F., D.C. Stokes, A.B. Cheatham, D.S. Davis, and W.T. Hughes. 1986. Development of murine monoclonal antibodies to Pneumocystis carinii. J. Inf. Dis. 154:315-322.
36. Qian, Q., M.A. Jutila, N. Van Rooijen, and J.E. Cutler, Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008.
37. Limper, A.H., and W.J. Martin. 1990. Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment. J. Clin. Invest. 85:391-396.
38. Bartlett, M.S., J.A. Fishman, S.A. Queener, M.M. Durkin, M.A. Jay, and J.W. Smith. 1988. New rat model of Pneumocystis carinii pneumonia. J. Clin. Microbiol. 26:1100-1102.
39. Limper, A.H., S.T. Pottratz, and W.J. Martin. 1991. Modulation of Pneumocystis carinii adherence to cultured lung cells by a mannose-dependent mechanism. J. Lab. Clin. Meet. 118:492-499.
40. Limper, A.H., J.E. Standing, O.A. Hoffman, M. Castro, and L.W. Neese. 1993. Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect. Immun. 61:4302-4309.
41. 125I-labeled tumor necrosis factor to Pneumocystis carinii and an insoluble cell wall fraction. J. Protozool. 38:28S-29S.
42. Bartlett, M.S., P.A. Vervanac, and J.W. Smith. 1979. Cultivation of Pneumocystis carinii with WI-38 cells. J. Clin. Microbiol. 10:796-799.
43. McDonald, J.A., B.J. Quade, TJ. Broekelmann, R. LaChance, K. Forsman, E. Hasegawa, and S. Akiyama. 1987. Fibronectin's cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix. J. Biol. Chem. 262:2957-2967.
44. McDonald, J.A., T.J. Broekelmann, M.L. Matheke, E. Crouch, M. Koo, and C. Kuhn III. 1986. A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis. J. Clin. Invest. 78:1237-1244.
45. Armstrong, M.Y.K., H. Koziel, R.M. Rose, C. Arena, and F.F. Richards. 1991. Indicators of Pneumocystis carinii viability in short term culture. J. Protozool. 38:88S-89S.
46. Berg, J.T., S.T. Lee, T. Thepen, C.Y Lee, and M.F. Tsan. 1993. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate. J. Appl. Physiol. 74:2812-2819.
47. Van Rooijen, N. 1989. The liposome-mediated macrophage "suicide" technique. J. Immunol. Method. 124:1-6.
48. Monkkonen, J., N. van Rooijen, and P. Ylitalo. 1991. Effects of clodronate and pamidronate on splenic and hepatic phagocytic cells of mice. Pharm. Toxicol. 68:284-286.
49. Monkkonen, J., H.M. Koponen, and P. Ylitalo. 1990. Comparison of the distribution of three bisphosphonates in mice. Pharm. Toxicol. 66:294-298.
50. Limper, A.H., U. Specks, W.M. Brutinel, W.J. Martin II, and M.S. Rohrbach. 1993. Interlobular variation in the recovery of bronchoalveolar lavage fluid, cell populations, and angiotensin-converting enzyme in normal volunteers. J. Lab. Clin. Med. 121:785-791.
51. O'Riordan, D.M., J.E. Standing, K.Y. Kwon, D. Chang, E.G. Crouch, and A.H. Limper. 1995. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J. Clin. Invest. 95:2699-2710.
52. Phelps, D.S., and R.M. Rose. 1991. Increased recovery of surfactant protein A in AIDS-related pneumonia. Am. Rev: Respir. Dis. 143:1072-1075.
53. Zimmerman, P.E., D.R. Voelker, F.X. McCormack, J.R. Paulsrud, and W.J. Martin. 1992. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J. Clin. Invest. 89:143-149.
54. Williams, M.D., J.R. Wright, K.L. March, and W.J. Martin II. 1996. Human surfactant protein A enhances attachment of Pneutnocystis carinii to rat alveolar macrophages. Am. J. Respir. Cell Mol Biol. 14:232-238.
55. Krishnan, V.L., A. Meager, D.M. Mitchell, and A.J. Pinching. 1990. Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin. Exp. Immunol. 80:156-160.
56. Chen, W., E.A. Haveell, and A.G. Harmsen. 1992. Importance of tumor necrosis factor-alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279-1284.
57. Pesanti, E.L. 1991. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro. J. Infect. Dis. 163:611-616.
58. Walzer, P.D., M. LaBine, T.J. Redington, and M.T. Cushion. 1984. Lymphocyte changes during chronic administration and withdrawal of corticosteroids: relevance to Pneumocystis carinii pneumonia. J. Immunol. 133:2502-2508.
59. Siminski, J., P. Kidd, G.D. Phillips, C. Collins, and G. Raghu. 1991. Reversed helper/suppressor T-lymphocyte ratio in bronchoalveolar lavage from patients with breast cancer and Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis. 143:437-440.
60. Huang, Z.B., and E. Eden. 1993. Effect of corticosteroids on IL1 beta and TNF alpha release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia. Chest. 104:751-755.
61. Garraud, O., A. Faucher, and E. Legrand. 1988. Impairment of monocyte functions in advanced head and neck cancer. Immunol. Lett. 18:213-218.